Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Presentation TCT 2024

TCT 390: Characteristics Associated With Optimal Stent Expansion in Patients With Calcified Lesions Receiving Rotational Atherectomy With or Without Cutting Balloon: A Secondary Analysis From the ROTA-CUT Randomized Trial

Presenter: Angelo Oliva

October 28, 2024

Presentation TCT 2024

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

Presenter: Kirstine Hansen

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

TCT 515: Optimal Antiplatelet Strategy for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. A trial-sequential, bivariate, influential, and network meta-analysis

Presenter: Harigopal Sandhyavenu

October 24, 2023

Presentation TCT 2023

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Presenter: Anna van Veelen

October 24, 2023

Presentation TCT 2023

Ten-Year Clinical Outcomes after PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients with STEMI: Extended Follow-Up of the EXPLORE trial

Presenter: Anna van Veelen

October 23, 2023

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Presenter: Shinichiro Masuda

September 19, 2022

Presentation TCT 2022

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

Presenter: Rachel Pathimagaraj

September 18, 2022

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Conference News TCT 2020

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Michael O'Riordan

October 21, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Michael O'Riordan

October 17, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

News Conference News TCT 2020

FFR Insights Before and After PCI: Fresh Food for Thought

Caitlin E. Cox

October 16, 2020

Advertisement

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

What’s Going to Be Hot at TCT 2025

TCT 390: Characteristics Associated With Optimal Stent Expansion in Patients With Calcified Lesions Receiving Rotational Atherectomy With or Without Cutting Balloon: A Secondary Analysis From the ROTA-CUT Randomized Trial

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

What’s Going to Be Big at TCT 2024?

TCT 515: Optimal Antiplatelet Strategy for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. A trial-sequential, bivariate, influential, and network meta-analysis

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Ten-Year Clinical Outcomes after PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients with STEMI: Extended Follow-Up of the EXPLORE trial

SCAAR Registry Delves Into Left Main Revascularization Outcomes

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

FFR Insights Before and After PCI: Fresh Food for Thought

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content